GridAI Technologies (GRDX) Cash & Current Investments (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Cash & Current Investments came in at $899784.0 in Q4 2025, up 450.41% YoY from $163476.0 in Q4 2024, and down 64.25% on a QoQ basis from $2.5 million in Q3 2025.
GridAI Technologies (GRDX) Cash & Current Investments (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Cash & Current Investments data on file, last reported at $899784.0 in Q4 2025.
- Quarterly Cash & Current Investments rose 450.41% year-over-year to $899784.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $899784.0 (up 450.41% YoY) and the FY2025 annual result came in at $899784.0, up 450.41% from the prior year.
- Cash & Current Investments eased to $899784.0 in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $12.0 million in Q1 2021 to a low of $8948.0 in Q2 2025.
- A 5-year average of $3.2 million and a median of $1.9 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 719.79% — and 2025, when it sank 98.73%.
- Tracing GRDX's Cash & Current Investments over 5 years: stood at $8.2 million in 2021, then tumbled by 82.97% to $1.4 million in 2022, then surged by 167.39% to $3.8 million in 2023, then plunged by 95.65% to $163476.0 in 2024, then jumped by 450.41% to $899784.0 in 2025.
- The last three Cash & Current Investments figures came in at $899784.0 (Q4 2025), $2.5 million (Q3 2025), and $8948.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 899,784.00 |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 8,948.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 163,476.00 |
| Sep 30, 2024 | 408,308.00 |
| Jun 30, 2024 | 703,995.00 |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 5.69 Mn |
| Dec 31, 2021 | 8.25 Mn |
| Sep 30, 2021 | 7.21 Mn |
| Jun 30, 2021 | 8.07 Mn |
| Mar 31, 2021 | 12.03 Mn |